CDKN2A and astrocytoma (excluding glioblastoma): Two primary astrocytomas had a CDKN2A/B homozygous deletion and this alteration was maintained upon recurrence whereas another seven primary astrocytomas acquired CDKN2A/B homozygous deletions over time (Fig. 6A, B).